Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. PureTech Health plc
  6. News
  7. Summary
    PRTC   GB00BY2Z0H74

PURETECH HEALTH PLC

(PRTC)
  Report
Delayed London Stock Exchange  -  11:35:10 2023-01-26 am EST
260.00 GBX   -1.89%
01/10Transcript : PureTech Health plc Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-10-2023 02:15 PM
CI
01/06PureTech Health Says ADHD Treatment Study Achieves Primary Efficacy Outcome
MT
01/06PureTech says ADHD treatment shows improved attentional functioning
AN
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

SVB Securities Adjusts PureTech Health's Price Target to $70 from $66, Keeps Outperform Rating

08/09/2022 | 11:11am EST
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about PURETECH HEALTH PLC
01/10Transcript : PureTech Health plc Presents at 41st Annual J.P. Morgan Healthca..
CI
01/06PureTech Health Says ADHD Treatment Study Achieves Primary Efficacy Outcome
MT
01/06PureTech says ADHD treatment shows improved attentional functioning
AN
2022TRADING UPDATES: Fiinu teams with TransUnion; GRC wins pact
AN
2022PureTech Provides End of Year Report on Key Progress
BU
2022PureTech Health plc Announces Executive Changes
CI
2022PureTech's LYT-300 (Oral Allopregnanolone) Demonstrates Oral Bioavailability, Tolerabil..
BU
2022PureTech Health plc Announces Topline Results from the Completed, Multi-Part Phase 1 Tr..
CI
2022PureTech to Present at 41st Annual J.P. Morgan Healthcare Conference
BU
2022PureTech Founded Entity Sonde Health Raises $19.25 Million Series B for Voice-Based Hea..
AQ
More news
Analyst Recommendations on PURETECH HEALTH PLC
More recommendations
Financials (USD)
Sales 2022 11,3 M - -
Net income 2022 -88,6 M - -
Net cash 2022 398 M - -
P/E ratio 2022 -8,04x
Yield 2022 -
Capitalization 896 M 896 M -
EV / Sales 2022 44,0x
EV / Sales 2023 50,6x
Nbr of Employees 95
Free-Float 84,4%
Chart PURETECH HEALTH PLC
Duration : Period :
PureTech Health plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PURETECH HEALTH PLC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 3
Last Close Price 3,21 $
Average target price 7,31 $
Spread / Average Target 128%
EPS Revisions
Managers and Directors
Daphne Zohar Chief Executive Officer & Executive Director
Bharatt M. Chowrira President, COO, CFO, Secretary & Director
Christopher A. Viehbacher Chairman
Joseph B. Bolen Chief Scientific Officer
Julie Krop Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
PURETECH HEALTH PLC-2.44%896
MODERNA, INC.7.49%74 174
LONZA GROUP AG15.21%42 087
IQVIA HOLDINGS INC.10.55%42 070
ALNYLAM PHARMACEUTICALS, INC.-3.63%28 176
SEAGEN INC.8.70%25 624